Together, the correlation between CSN6, FASN, and de novo lipid synthesis could be recapitulated in mouse xenograft cancer study, and tumor suppressive impact of orlistat in inhibiting FASN and lipid synthesis can be explored in hindering CSN6-overexpressing tumorigenicity. Here, FASN is linked to cancer.